Alcohol Consumption Emerges as a Key Risk Factor for Buccal Cancer in India
December 24, 2025
Brand Name :
Periactin
Synonyms :
cyproheptadine
Class :
Antihistamines
Dosage Forms & Strengths
Tablet
4mg
Oral solution
2mg/5mL
4
mg
Orally
3 times a day; may be increase up to 4-20 mg/day
In some cases, up to 32 mg/day divided 3 times
Do not exceed 0.5 mg/kg/day
inicated for Spasticity Associated with Spinal Cord:
2 - 4
mg
Orally
3 times a day
Do not exceed 24 mg per day
Migraine Headache Prophylaxis :
2
mg
Orally
twice a day; w/wo propanol
Appetite Secondary To Chronic Disease
Indicated for Decreased Appetite Secondary to Chronic Disease :
2
mg
Orally
4 times a week; then 4 mg orally 4 times a week
Drug-Induced Sexual Dysfunction
4 - 12
mg
orally
1–2 hours prior to anticipated coitus or 1–16 mg daily
12
mg
orally
, then 2 mg every two hours or 4–8 mg every six hours as necessary to treat symptoms
Dosage Forms & Strengths
Tablet
4mg
Oral solution
2mg/5mL
Age: >3 years and adolescents :
0.2 - 0.4
mg/kg/day
orally
divided 2 times a day; do not exceed 0.5 mg/kg/day
Age: 2-6 years :
2
mg
orally
2-3 times a day; do not exceed 12 mg/day
Age: 7-14 years
4 mg orally 2-3 times a day; do not exceed 16 mg/day
Alternatively, total daily dose of 0.25 mg/kg or 8 mg/m²
Age: >13 years :
2
mg
Orally
4 times; may be increased to 8 mg 4 times over 3 weeks
Refer to adult dosing
may decrease the diagnostic effect when combined with metyrapone
may increase the anticholinergic effect of Cyproheptadine
it may diminish the therapeutic efficacy when combined with castor oil
When cyproheptadine is used together with melitracen, this leads to enhanced risk or seriousness of CNS depression
When ponesimod is used together with cyproheptadine, this leads to enhanced risk or seriousness of bradycardia
When cyproheptadine is used together with adenosine, this leads to enhanced risk or seriousness of QTc prolongation
When cyproheptadine is used together with givinostat, this leads to enhanced risk or seriousness of Qtc prolongation
When emylcamate is used together with cyproheptadine, this leads to enhanced risk or seriousness of CNS depression
When acepromazine is used together with cyproheptadine, this leads to enhanced risk or seriousness of CNS depression
When cyproheptadine is used together with profenamine, this leads to enhanced risk or seriousness of adverse events
Actions and Spectrum:
Its actions include:
The spectrum of cyproheptadine includes a wide range of conditions that it can be used to treat, including:
Frequency Not Defined
Drowsiness
Lassitude
Dizziness
Disturbed coordination
Restlessness
CNS depression
Less commonly
Insomnia
Seizures
Tremors
Toxic psychosis
Palpitation
Paresthesia
Tachycardia
Hypotension
Palpitation
Black Box Warning
The black box warning for cyproheptadine states that the drug can cause a potentially fatal condition called serotonin syndrome when used in combination with certain antidepressants, such as selective serotonin reuptake inhibitors (SSRIs) or monoamine oxidase inhibitors (MAOIs).
Contraindication/Caution:
Contraindications:
Cautions:
Pregnancy warnings:
US FDA pregnancy category: B
Lactation:
Excreted into human milk is unknown
Pregnancy Categories:
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.
Category B: There were lack of studies on pregnant women and no evidence of risk to the foetus in animal experiments.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
cyproheptadine is an antihistamine and serotonin antagonist medication that is used to treat a variety of conditions, including allergic reactions, migraines, and insomnia.
Pharmacodynamics:
The mechanism of action of cyproheptadine is primarily through its antihistamine properties, which work by blocking the action of histamine, a chemical that is released by the body during an allergic reaction. By blocking the action of histamine, cyproheptadine can reduce symptoms such as sneezing, itching, and runny nose.
Pharmacokinetics:
Absorption
cyproheptadine is rapidly and well absorbed after oral administration, with peak plasma concentrations occurring within 1-2 hours
Distribution
cyproheptadine is widely distributed throughout the body, including the brain and other organs. It has a large volume of distribution, which suggests that it is highly protein-bound in plasma.
Metabolism
cyproheptadine is metabolized in the liver by the enzyme CYP3A4
Elimination and excretion
cyproheptadine is eliminated primarily by the liver and is excreted in the urine and feces. The half-life of the drug is approximately 12 hours, which means that it remains active in the body for a relatively long period of time.
Administration:
Oral Administration
cyproheptadine is a medication that is typically administered orally in the form of a tablet or syrup. The dosage and frequency of administration will depend on the condition being treated and the individual patient’s response to the medication.
For the treatment of allergic reactions, the usual adult dosage is 4 mg three or four times a day. For the treatment of migraines, the usual adult dosage is 4 mg twice a day. For the treatment of serotonin syndrome, the usual adult dosage is 12 mg per day in divided doses.
Patient information leaflet
Generic Name: cyproheptadine
Why do we use cyproheptadine?
cyproheptadine is a medication that is primarily used to treat allergic reactions, migraines, and serotonin syndrome.